Skip to NavigationSkip to content

Pharmafile - Sales and Marketing News

A new digital therapeutic available for use without prescription under the FDA’s emergency guidance for digital health devices has shown to cut...
NICE has issued a positive final appraisal document recommending upadacitinib, a once-daily oral therapy, for people with previously treated moderate...
Swedish pharmaceutical company AlzeCure Pharma AB has announced the initiation of the company’s next clinical Phase I trial (multiple ascending dose...
SEED Innovations Ltd has announced that it has invested a further £150,000 in South West Brands Limited (SWB), a multi-brand consumer goods group...
Bayer has revealed positive results from their FIGARO-DKD Phase III trial of Kerendia (finerenone), which showcased the drug’s ability to reduce risk...
Eli Lilly and Mumbai-based Cipla have announced a deal in which Cipla will sell and distribute two of Lilly’s best-selling diabetes treatments in...
AstraZeneca and Daiichi Sankyo have today announced that the FDA has granted Enhertu (fam-trastuzumab deruxtecan-nxki) breakthrough therapy...
Multinational pharmaceutical company, Hikma Pharmaceuticals PLC, has announced that it has agreed to acquire Custopharm Inc from Water Street...
Vifor Fresenius Medical Care Renal Pharma (VFMCRP) has announced that Japan’s Ministry of Health and Labour Welfare (MHLW) has granted marketing...
A clinical study of the combination of AstraZeneca and Sputnik Light vaccines, conducted in Azerbaijan, has revealed strong neutralising antibodies...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches